First Time Loading...

Iterum Therapeutics PLC
NASDAQ:ITRM

Watchlist Manager
Iterum Therapeutics PLC Logo
Iterum Therapeutics PLC
NASDAQ:ITRM
Watchlist
Price: 1.57 USD -2.48%
Updated: May 10, 2024
ITRM
/
Income Statement
/
Income from Continuing Operations

Iterum Therapeutics PLC
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Iterum Therapeutics PLC
Income from Continuing Operations Peer Comparison

Comparables:
PRGO
JAZZ
AVDL
G
GHRS
COPN

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
Iterum Therapeutics PLC
NASDAQ:ITRM
Income from Continuing Operations
-$38.4m
CAGR 3-Years
10%
CAGR 5-Years
13%
CAGR 10-Years
N/A
Perrigo Company PLC
NYSE:PRGO
Income from Continuing Operations
-$4.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
Income from Continuing Operations
$334.1m
CAGR 3-Years
-14%
CAGR 5-Years
-7%
CAGR 10-Years
15%
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
Income from Continuing Operations
-$160.3m
CAGR 3-Years
-324%
CAGR 5-Years
-11%
CAGR 10-Years
-13%
G
GH Research PLC
NASDAQ:GHRS
Income from Continuing Operations
-$35.6m
CAGR 3-Years
-329%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Cosmo Pharmaceuticals NV
SIX:COPN
Income from Continuing Operations
€1.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-33%

See Also

What is Iterum Therapeutics PLC's Income from Continuing Operations?
Income from Continuing Operations
-38.4m USD

Based on the financial report for Dec 31, 2023, Iterum Therapeutics PLC's Income from Continuing Operations amounts to -38.4m USD.

What is Iterum Therapeutics PLC's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
13%

Over the last year, the Income from Continuing Operations growth was 14%. The average annual Income from Continuing Operations growth rates for Iterum Therapeutics PLC have been 10% over the past three years , 13% over the past five years .

ALPHA SPREAD
Join more than 136,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.